That's funny. A handful of people on the Geron Yahoo message board are going to bring down INCY. LOL
What will allow Geron is gooble up INCY's sales is the fact that Imetelstat produces CRs and PRs and Jackoffi does no.
If ACT refuted claims made on SA that would be a said day. No legitimate companies "refute" pseudo experts on SA. There are not facts it's just unsubstantiated claims made by someone that trades in and out of the stock.
They don't realized the ticker symbol changed. #$%$ is still spamming right wing garbage on the ACTC message board.
Don't start this nonsense again. We went through the same thing with the ASTY distribution. The record date identifies to whom the company will issue the warrants. If you sell between the record date and the ex-div date your brokerage will forward your warrants to the person you sold your shares to. End of story. Please don't mislead people.
He never said they would not pursue solid tumors. He made a statement on the lines that resources would be directed toward hematological cancers. He left open the possibility that they could return to it at some point in the future. I will try to find the actual text.
It would be interesting to know if the patients are still receiving Imetelstat or they are just being observed. Perhaps there was an interesting subgroup that is responding. The lung cancer trial is "completed".
Also, the ET trial is listed as "suspended" and the MM trial is listed as "active, not recruiting". This seem inconsistent given the they are both on FDA hold.
Seems like you are posting stuff that contradicts what you have been preaching. I would contend that FDA panels whose members are influenced by big pharma rsearch funding and the money they receive for consulting is "corrupt".
It reminds me of a line from a movie when someone was upset he wasn't getting a local politicians support. He said in the good ole days when you bought a politician he stayed bought.
What an Arzzss. Making up garbage about a trial that patients are pinning their hopes on. You are a low life.
That is a good question but the Yahoo message board is unlikely to provide a knowledgeable response.
The claim is that hpSC cell lines immune match a large portion of the population and with multiple cell lines they would match a majority of the population. Aside from the immune advantage over hESC I have seen little discussion as to whether the cells work as well as hESCs.
I'm not an authority. Go read the SEC filing when they gave away the rights to TA-65 in exchange for them not being able to mention Geron. If you want to keep some false hope alive go ahead.